US EditionModifi Biosciences is acquired by Merck
Summary by Union News Daily
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Modifi Biosciences is acquired by Merck
Dr. Ranjit S. Bindra, Modifi Biosciences co-founder RAHWAY, NJ — Modifi Biosciences Inc., a leader in the development of direct DNA modification enabled cancer therapeutics, has been recently acquired by Merck and Co. Inc. Modifi Biosciences, a Yale University spinout company formed in 2021, has developed a novel class of small molecules that target cancer cells lacking express of a key DNA repair protein called O⁶-Methylguanine-DNA Methyltransf…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
